Linc AB (STO:LINC)

Market Cap	3.64B
Revenue (ttm)	-84.33M
Net Income (ttm)	-80.36M
Shares Out	57.91M
EPS (ttm)	-1.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,771
Average Volume	50,721
Open	62.90
Previous Close	62.80
Day's Range	62.30 - 62.90
52-Week Range	59.00 - 83.60
Beta	0.84
RSI	34.22
Earnings Date	Jan 22, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC

Financial Performance

In 2024, Linc AB's revenue was 1.29 billion, an increase of 95.80% compared to the previous year's 659.45 million. Earnings were 1.30 billion, an increase of 110.12%.